Live chat
Joslin Diabetes Center

Interpreter (Independent Consultant/Contract)

Joslin Diabetes Center - Boston, MA

Joslin Diabetes Center is seeking Contract (Independent Consultant) Medical Interpreters.
Languages needed are Korean, or Vietnamese or American Sign Language (ASL).
The Interpreter will relay medical information between speakers of English and Korean/Vietnamese/ASL in compliance with all office and hospital policies and procedures, particularly relating to patient confidentiality and informed consent, passing performance of competencies listed in the MMIA Standards of Practice, and the Code of Ethics.

Interpreting: 1 year (Required)
Medical Interpreting: 1 year (Required)
Medical Interpreter: 1 year (Required)

Must be bilingual in either Korean, or Vietnamese. or ASL and English
Formal medical interpreting training and satisfactory knowledge of medical terminology is required.
1-year experience in a healthcare setting as a medical interpreter is strongly preferred.
Proof of medical interpreter training - minimum of 40 hours (college level interpreting training and National Certification preferred)
High level of customer service and a positive approach
General knowledge of cultural backgrounds of patients to be served
Good interpersonal, organizational, and time-management skills
Knowledge of video communication software
Ability to accurately work in consecutive mode and sight translate into and from working language(s).

Joslin Diabetes Center is an Equal Opportunity Employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability status, protected veteran status or any other status protected by law.

13 days 14 hours ago

Joslin Diabetes Center


Interpreter (Independent Consultant/Contract) Joslin Diabetes Center - Boston, MA, United States


Location: Boston, MA

Company Profile:
Joslin Diabetes Center, a teaching and research affiliate of Harvard Medical School, is a one-of-a-kind institution on the front lines of the world epidemic of diabetes — leading the battle to conquer diabetes in all of its forms through cutting-edge research and innovative approaches to clinical care and education.